Ruti Aga: A Family Member's Prescription, a Six-Year Ban, and the Ledger of a Marathon Career

On a reception desk in an Addis Ababa clinic, a prescription was set down for verification. There was a seal, a pad, a drug name, a patient name. One thing did not reconcile: the pad it was written on had left that clinic's register years earlier. The answer from behind the desk was not a medical opinion. It was an office ledger entry: this pad is not ours.

That single sentence rewrote a marathon career's arithmetic. Ruti Aga, thirty-two, Ethiopia. Winner of the 2026 Tokyo Marathon, runner-up at three World Marathon Majors. In the hearing room, one sheet of paper sat in front of her. It had been written by a member of her own family with no medical registration. The subject was a knee. The outcome was six years.

Athletic careers usually end on a clock. This one ended on a pad number.

I watched the 2026 Tokyo Marathon from a desk in Dhaka, in the early hours, not touching a cup of tea long after it went cold. The read that morning was simple: an Ethiopian who kept finishing second at the Majors had finally finished first. That remains the high point of her career. Beside it sit three further Major runner-up finishes.

Put those results together and the picture is not dominance. It is reliability. A runner who is around the podium at nearly every Major, who does not fold on the big day, and around whom no event was ever built. On the global marathon order that places her inside the top fifteen to twenty-five of her generation. That is not a small thing. It is precisely the band where income comes from appearance fees and podium bonuses rather than global brand contracts.

The trigger sits in one line of the file: a half marathon in China in March, which she won, and a sample taken after that win that returned methylprednisolone. Methylprednisolone is a glucocorticoid, used to reduce inflammation, and it is prohibited in competition under the WADA framework. Her explanation was a knee injury.

A knee injury is not an implausible story for a marathoner. Patellofemoral load, long weeks on highland roads, kilometres accumulated on unsurfaced tracks away from the stadium: the knee is an occupational risk in this sport. The drug is not surprising either. The surprise is the paper.

The prescription submitted was written by a family member with no medical registration. There is a further layer. That person said the pad used came from a former workplace. The clinic named on the pad stated flatly that it was not theirs and had been retired years earlier.

The arithmetic of the sanction is not straightforward. Of the six years, four come from the tampering provision, meaning improper conduct around a sample or documentation. The file indicates no prior sanction history. The escalation was not driven by repetition. It was driven by a forged document. The ban runs from 10 September; the year of the decision is not stated in the material, and that is a gap worth holding onto when reconciling the ledger.

The punishment here is calendrical, not moral.

In a marathoner's body, the glucocorticoid question is not really a drug question. It is a scheduling question. Under the WADA framework this class is prohibited in competition and permitted out of it. The same injection in June, properly documented and cleared, is treatment. The same injection in race week, detectable in a sample, is a violation. The panel did not ask whether she took a drug. It asked when.

This drug does not build muscle. It reduces inflammation and masks pain. The prohibition rests on two logics: masking pain permits racing on an injury that should have kept an athlete out, and this class can also be used to hide the markers of other substances. The rule targets the day, not the body.

This is where professional infrastructure becomes decisive. A licensed team physician with TUE literacy had three routes: move the injection far enough ahead of the race, apply for the appropriate clearance, or withdraw the athlete. The relative holding the pad could take none of them. He wrote a document.

A marathoner in pain tends to think about whether she can run on Sunday. She does not think about where her sample window falls. Careers end in the gap between those two thoughts.

Because she is second-tier elite, the damage is close to total.

Road running's economy is built off the track. A marathoner's earnings come largely from appearance fees, podium bonuses, time-based contracts and winner's prize money. Global ambassadorship belongs to the top five. Aga sits outside that group, exactly where income depends on how often she can race over the next six months.

Six years means zero. A ban beginning at thirty-two produces a return at roughly thirty-eight. The marathon's extended peak runs from about twenty-seven to thirty-three; outliers exist, but outliers are manufactured inside planned training, racing and testing systems. Six years outside competition and outside the testing system is not merely lost form. It is a lost network of agent, coach, training camp and sponsor, all at once.

The road market right now is a start-money market. Agents price runners off recent marks; an annulled result means one line erased from a CV, and that line set next season's price. One note in passing: agents generate far more noise than measurable value, yet the problem in this file runs the other way. In an agent-driven market, the professional protection an athlete needs around her simply does not exist.

High fee, low surveillance is the address of the mid-tier elite.

That March half marathon was a label road race in China. The profile is familiar: appearance-fee driven, outside the regular gaze of the elite circuit, with a testing footprint set by the local anti-doping organisation and targeted Athletics Integrity Unit work rather than by the race's commercial weight.

This is where a mid-tier elite spends most of her season and is tested least often. On a Diamond League stage there are eyes every week. At a March half marathon the eyes arrive after the result is already published.

Four things are missing from the file, and those four gaps make the mark impossible to position: the name of the race, the winning time, the course profile, and the sample type, whether urine or blood. Road results cannot be read without a clock. Altitude, women-only versus mixed pacing, and the first-generation super-shoe dividend all matter, and none can be reconstructed here. Her peak marks from 2026 and 2026 already sit partly inside that first carbon-plate generation; a full shoe-era deduction is not possible without course-level data.

The record book forgets; the clock does not. But the clock only helps when the time is written down somewhere. Here it is not. What is written down is a date.

What got caught was not the injection. It was the paperwork.

Read closely and a structure emerges. The knee hurts, the race is close, a fast solution is needed. In that moment an athlete calls the person who answers fastest, not the person most qualified. In the Ethiopian highland camps the triangle of coach, agent and medical support is often informal. Talent arrives from the roads, training from the mountains, and treatment from a personal network.

Most of the time the informality costs nothing, because nobody cross-checks. This time somebody cross-checked.

A parallel from my own beat does not map exactly, but the structural question is the same. At the National Athletics Championships in Dhaka, the services teams have physios; the athlete who came up from a district has nobody. The discus thrower hunting an ice pack twice a week at Bangabandhu National Stadium and the marathoner in an Addis camp face one question with one missing answer. Rangpur taught me that empty lanes still have a pulse; an athlete without paperwork is that empty lane, and nobody is counting the pulse.

The difference is only currency. An Ethiopian runner loses six years to a forged prescription. A district athlete in Bangladesh loses to the absence of a synthetic track, with no document involved at all.

The mark that now matters is not a time. It is an annulment.

The March half marathon result will be disqualified, with title, prize money and ranking points. The 2026 Tokyo title survives this decision because it is not connected to that sample. Two lines under one name. One stays, one is struck.

The archive is a stadium where the crowd never leaves. Only ratified results enter the record book, and the next generation learns from that book who was fast. The struck line will not be read. The surviving line will be read by everyone. This file is therefore less a question of performance analysis than of retention policy: who decides which number stays in history.

On the road this is harder than on the track. On the track a machine takes the time, video bears witness, the course is fixed. On the road the course changes, wind is not gauged, pacing formats differ and the governing body differs. Road results therefore need more paper to verify. Here the paper was false.

The harshest sanction landed on the athlete whose paperwork was easiest to read.

The first reading is simple: another one caught. The second reading is uncomfortable. The sanction in this case rests on the drug and on the document, and the document is what extended it. The tampering provision has a sound rationale: a forged document attacks the process itself and deserves its own penalty. The problem is not the logic. It is the distribution.

An athlete surrounded by an established medical team, lawyers and communications staff tends to end up at a negotiated table. An athlete alone, whose only adviser is a relative, ends up on the toughest provision. Sanction severity ends up tracking not how deep the offence ran but how legible the paperwork was.

That does not soften the drug. It raises the opposite question: if a system is better at reading documents than at detecting substances, its heaviest penalties will fall on the cases where the offence is smallest, because that is where the paperwork is thickest.

The six years will not be reversed. What can change is the next athlete's preparation. Talent scouting in the Ethiopian highlands happens on the roads. Putting a registered medical desk in those camps costs less than the current marathon order. Race organisers pay out appearance fees in the millions each season; a small share of that budget spent on medical literacy in the camps would mean the next prescription is not written on a retired pad.

The 2026 Tokyo line stays in the book. The March line goes. I write about sport because the clock is never just a clock. Sometimes a seal has to be set beside it, and that seal decides who remains in history.

Whether the ban was severe is no longer the question. The question is who will put a registered doctor in the next Ruti Aga's camp, and if nobody does, who will write the ledger for the next six years.